Clinical Trials - Closed
-
A5350: Effects of Visbiome Extra Strength on Gut Microbiome and Immune Activation Markers
Study Location:
Eligibility: Participants in the study must: Have HIV infection Be on stable HIV treatment for at least the last 24 weeks Have...
Enrollment: Closed
-
A5342: Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)
Study Location: Baltimore
Eligibility: Ages Eligible for Study: 18 Years to 65 Years Genders Eligible for Study: Both Accepts Healthy Volunteers: ...
Enrollment: Closed
-
HPTN 069: A Phase II Randomized, Double-Blind, Study of the Safety and Tolerability of Maraviroc (MVC), Maraviroc + Emtricitabine (MVC+FTC), Maraviroc + Tenofovir disoproxil fumarate (MVC+TDF)
Study Location: Baltimore
Eligibility: HIV-uninfected at-risk MSM and at-risk women > 18 years.
Enrollment: Closed
-
A5314: Effect of LDMTX on Inflammation in HIV-infected Individuals
Study Location: Baltimore
Eligibility: HIV-infected men and women ≥40 years old, who have been virologically suppressed on continuous antiretroviral therapy for at...
Enrollment: Closed
-
A5273: Multicenter Study of Options for Second-Line Effective Combination Therapy (SELECT)
Study Location: India
Eligibility: Human immunodeficiency virus (HIV)-1 infected adults (age ≥18 years) who have confirmed virologic failure on an...
Enrollment: Closed
-
P1077FF: Formula Feeding Version of the PROMISE Study (Promoting Maternal and Infant Survival Everywhere)
Study Location: India
Eligibility: Antepartum Component – HIV-infected pregnant women who intend to formula feed (FF) (with and without HBV) with documented...
Enrollment: Closed